No abstract available
biologics; nanocarriers; nucleic acid medicines; protein drugs; targeting.
Grants and funding
AD acknowledges the financial support of the Interstellar Initiative Program (22jm0610071h0001) from the Japan Agency for Medical Research and Development (AMED), Grants-in-Aid for Early-Career Scientist (21K18062 and 18K18393) and Scientific Research (C) (23K11841) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT). JL acknowledges the financial support of Grants-in-Aid for Early-Career Scientist (20K20209) and Scientific Research (B) (23H03740). DG-C acknowledges financial support through a “La Caixa Foundation” Junior Leader Research Fellowship (LCF/BQ/PI20/11760003).